ICU Medical, Inc. (NASDAQ:ICUI) Director Robert S. Swinney sold 463 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $181.25, for a total value of $83,918.75. Following the completion of the sale, the director now owns 14,330 shares in the company, valued at approximately $2,597,312.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of ICU Medical, Inc. (ICUI) traded down 0.63% during midday trading on Friday, reaching $180.05. The company had a trading volume of 117,112 shares. ICU Medical, Inc. has a 52 week low of $120.93 and a 52 week high of $182.45. The company’s 50 day moving average price is $172.26 and its 200-day moving average price is $163.56. The company has a market capitalization of $3.57 billion, a P/E ratio of 72.11 and a beta of 0.36.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company had revenue of $331.51 million for the quarter, compared to analysts’ expectations of $318.30 million. During the same quarter last year, the company earned $1.15 EPS. ICU Medical’s revenue for the quarter was up 242.8% compared to the same quarter last year. On average, equities research analysts predict that ICU Medical, Inc. will post $4.11 earnings per share for the current fiscal year.
A number of equities analysts have recently issued reports on the company. Gabelli reissued a “buy” rating on shares of ICU Medical in a research report on Friday, August 11th. BidaskClub downgraded ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Zacks Investment Research downgraded ICU Medical from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 15th. Finally, Sidoti downgraded ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company. ICU Medical presently has an average rating of “Hold” and an average target price of $193.00.
Hedge funds and other institutional investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in ICU Medical by 10.3% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 707 shares of the medical instruments supplier’s stock worth $122,000 after purchasing an additional 66 shares during the period. Riverhead Capital Management LLC boosted its position in shares of ICU Medical by 99.8% during the 2nd quarter. Riverhead Capital Management LLC now owns 999 shares of the medical instruments supplier’s stock worth $172,000 after acquiring an additional 499 shares in the last quarter. Victory Capital Management Inc. boosted its position in shares of ICU Medical by 17.6% during the 2nd quarter. Victory Capital Management Inc. now owns 1,050 shares of the medical instruments supplier’s stock worth $181,000 after acquiring an additional 157 shares in the last quarter. Parametrica Management Ltd acquired a new position in shares of ICU Medical during the 2nd quarter worth about $213,000. Finally, Teacher Retirement System of Texas acquired a new position in shares of ICU Medical during the 2nd quarter worth about $214,000. Institutional investors own 78.13% of the company’s stock.
ICU Medical Company Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.